Valuation: RaySearch Laboratories AB

Market Cap 6.08B 606M 539M 503M 458M 864M 58.29B 872M 2.36B 29.8B 2.28B 2.23B 95.63B P/E 2026 *
22.6x
P/E 2027 * 18.2x
Enterprise Value 6.24B 622M 552M 516M 470M 886M 59.77B 895M 2.42B 30.56B 2.33B 2.28B 98.07B EV / Sales 2026 *
4.47x
EV / Sales 2027 * 3.73x
Free-Float
80.09%
Yield 2026 *
2.21%
Yield 2027 * 2.64%
1 day-0.43%
1 week+6.11%
Current month-1.71%
1 month+4.19%
3 months-19.45%
6 months-5.54%
Current year-19.47%
1 week 175.35
Extreme 175.35
187.4
1 month 167
Extreme 167
187.4
Current year 161
Extreme 161
237
1 year 161
Extreme 161
262
3 years 79.99
Extreme 79.9948
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+6.11% - - 606M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average -0.20%-2.50%-0.56%+21.33% 91.4B
Weighted average by Cap. +0.15%-3.27%+3.37%+21.48%

Financials

2026 *2027 *
Net sales 1.4B 139M 124M 115M 105M 198M 13.38B 200M 541M 6.84B 522M 511M 21.95B 1.63B 163M 144M 135M 123M 232M 15.63B 234M 632M 7.99B 610M 597M 25.64B
Net income 272M 27.1M 24.08M 22.48M 20.49M 38.64M 2.61B 39M 105M 1.33B 102M 99.55M 4.27B 338M 33.63M 29.88M 27.89M 25.42M 47.94M 3.23B 48.39M 131M 1.65B 126M 124M 5.3B
Net Debt 155M 15.45M 13.72M 12.81M 11.67M 22.02M 1.48B 22.22M 60.06M 759M 57.99M 56.73M 2.44B 7M 698K 620K 578K 527K 994K 67.05M 1M 2.71M 34.28M 2.62M 2.56M 110M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
02/10/26 SEK 183.40 -1.45% 2,307
01/10/26 SEK 186.10 -0.59% 7,268
30/09/26 SEK 187.20 +1.13% 269
29/09/26 SEK 185.10 +4.11% 1,513
28/09/26 SEK 177.80 +2.54% 234
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
181.00SEK
Average target price
297.50SEK
Spread / Average Target
+64.36%

Quarterly revenue - Rate of surprise